Cascade Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
38,343
+570
+2% +$25.5K 0.89% 43
2026
Q1
$1.82M Buy
37,773
+685
+2% +$31.9K 1.08% 31
2025
Q4
$1.8M Buy
37,088
+425
+1% +$21.1K 1.06% 36
2025
Q3
$1.73M Buy
36,663
+2,119
+6% +$102K 1.05% 33
2025
Q2
$1.67M Buy
34,544
+175
+0.5% +$8.94K 1.07% 35
2025
Q1
$1.91M Sell
34,369
-1,100
-3% -$59.5K 1.29% 25
2024
Q4
$1.71M Buy
35,469
+150
+0.4% +$7.63K 1.1% 29
2024
Q3
$2.04M Buy
35,319
+160
+0.5% +$8.64K 1.3% 23
2024
Q2
$1.71M Buy
35,159
+800
+2% +$38.6K 1.15% 28
2024
Q1
$1.67M Buy
34,359
+1,535
+5% +$75K 1.09% 35
2023
Q4
$1.63M Buy
32,824
+9,540
+41% +$466K 1.16% 32
2023
Q3
$1.25M Buy
+23,284
New +$1.24M 0.99% 43
2021
Q3
Sell
-150
Closed -$7.9K 268
2021
Q2
$7.9K Hold
150
0.01% 237
2021
Q1
$7.42K Buy
+150
New +$7.21K ﹤0.01% 244

Other funds holding SNY

Cascade Investment Advisors's SNY Position: Q2 2026 in Review

Cascade Investment Advisors increased its Sanofi (SNY) stake by 1.5% in Q2 2026, buying an estimated $25.5K and bringing the position to 38,343 shares worth $1.64M. The position accounts for 0.89% of the portfolio, ranked #43.

Cascade Investment Advisors first reported a position in SNY in Q1 2021 and has held it in 14 quarters since. The position peaked at $2.04M in Q3 2024. 181 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cascade Investment Advisors held 38,343 shares of Sanofi worth $1.64M as of Q2 2026.
  • Cascade Investment Advisors bought 570 Sanofi shares in Q2 2026, an estimated $25.5K.
  • Sanofi made up 0.89% of Cascade Investment Advisors's portfolio in Q2 2026, its #43 holding.
  • Cascade Investment Advisors first reported a position in Sanofi in Q1 2021 and has held it in 14 quarters since.
  • Cascade Investment Advisors's Sanofi position peaked at $2.04M in Q3 2024.
  • 181 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cascade Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.